Genmab A (GMAB) Non-Current Deferred Tax Liability (2024 - 2025)

Genmab A's Non-Current Deferred Tax Liability history spans 2 years, with the latest figure at $364.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability rose 10.3% year-over-year to $364.0 million; the TTM value through Dec 2025 reached $364.0 million, up 10.3%, while the annual FY2025 figure was $364.0 million, 10.3% up from the prior year.
  • Non-Current Deferred Tax Liability reached $364.0 million in Q4 2025 per GMAB's latest filing, up from $330.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $364.0 million in Q4 2025 to a low of $330.0 million in Q4 2024.